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Mid-term Results of Neck-Related Adjunctive Therapies Utilized Dur-
ing Endovascular Repair of Infra-Renal Aortic Aneurysms
Jayer Chung, Karthikeshwar Kasirajan, Ross Milner, Naren Gupta, Elliott
Chaikof, Ravi Veeraswamy. Emory University Hospital, Atlanta, GA
Objective: To determine event-free survival in patients requiring ad-
junctive aortic neck procedures during endovascular aneurysm repair
(EVAR).
Methods: A retrospective review of 172 patients undergoing EVAR
between 01/05 and 09/07 was performed. Data were analyzed by the
need for an adjunct, defined as a proximal aortic cuff, Palmaz stent, or
high-pressure balloon angioplasty. The primary outcome was event-free
survival defined as survival without type I endoleak, sac enlargement,
rupture, or subsequent neck-related procedure. Secondary outcomes
included aneurysm-related and all-cause mortality, and any aneurysm-
related secondary procedures. Univariate analyses determined the rela-
tionship of outcome variables to aortic neck length, diameter, angula-
tion, thrombus, presence of a reverse taper, endograft type, Palmaz stent
use, and patient comorbidities.
Results: 53 patients had 56 adjunctive neck-related procedures with a
technical success rate of 97%. 119 patients did not require an adjunct. The
one-year event-free survival was similar between the groups (96% and 98%
respectively, p  0.88). There were no ruptures. 44 patients (83%) who
received an adjunct had “hostile” neck anatomy. Univariate analysis revealed
that placement of a Palmaz stent was associated with a reduction in event-
free survival (p  0.04). No other predictors of event-free survival were
identified.
Conclusions: Adjunctive treatment to the proximal neck does not
compromise mid-term results for EVAR. Palmaz stent placement may
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Background: Aim of this study was to assess the safety and the
effectiveness in the early period of a new generation device (Endurant
stent-graft) developed to treat patients suffering from abdominal aortic
aneurysms (AAAs) with hostile aortoiliac anatomy.
Methods: From November 2007 to October 2008, 45 patients suffer-
ing from an AAA were treated with an Endurant stent-graft in three
European vascular departments. Data from all interventions were prospec-
tively collected in a dedicated database. Intraoperative, early (30 days) and
6-month results in terms of technical success, clinical success, morbidity and
mortality were assessed.
Results: Patients were predominantly males (44 cases, 97.8%), with a
mean age of 72.7 years (range 51-86). Thirty-eight (84.4%) patients had a
hostile anatomy of the proximal neck; major iliac calcifications were present
in 41 patients (91.1%). Intraoperative technical and clinical success was
achieved in all the cases. At the completion angiography a type II endoleak
was detected in 7 patients (15.5%); in 5 patients (11.1%) an iliac branch
stenosis was diagnosed and successfully treated. The mean hospital stay was
4.9 days (range 3-8); during this period, an increase of creatinine serum
value, an atrial fibrillation and a false aneurysm in the groin were recorded.
Seven patients (15.5%) had a postimplantation syndrome. At discharge,
CT-scan examination showed one type I endoleak (2.2%) and the persis-
tence of two type II endoleaks. Moreover, at 30 days, a graft thrombosis was
diagnosed (2.2%) and successfully treated. The 30-day overall technical
success and clinical success rates were 97.7% and 95.6%, respectively. During
the follow-up (mean duration 6 months; range 3-14) there were no death,
rupture, conversion, migration or reintervention. CT-scan examinations
showed the persistence of the endoleaks diagnosed at discharge. Estimated
absences of type I/III endoleak and reintervention at 6 months were both of
95.6%.
Conclusions: Our preliminary experience shows that Endurant
stent-graft appears to be effective in endovascular exclusion (EVAR) of
AAAs in patients with hostile aortoiliac anatomy. The special features of
the graft allow a broader group of patients to be treated with EVAR, even
if further studies are needed to evaluate long-term results of this new
device.
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Objective: Since the FDA approval of endovascular aortic aneurysm
repair (EVAR) devices, there has been a gradual transition from a physio-
logic to an anatomic criteria case selection. The economic implications of
this evolving selection criteria have not been widely studied. The objective of
this study is to investigate the cost-effectiveness of elective EVAR compared
to OPEN abdominal aortic aneurysm (AAA) repair, in low and high risk
patients.
Methods: A retrospective analysis was performed reviewing all patients
who underwent an elective AAA repair between 2004 and 2007. Clinical
endpoints included postoperative stay, postoperative complications and
30-day mortality. Total hospital cost associated with the index procedure
was obtained. The study population was divided into high (SVS score  8)
